The John Sheldon memorial lecture. Review of nasal therapy: update.
D000042:Absorption; D004205:Cromolyn Sodium / Q000627:therapeutic use; D003907:Dexamethasone / Q000378:metabolism / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D006636:Histamine Release; D006801:Humans; D007167:Immunotherapy; D009299:Nasal Provocation Tests; D010447:Peptide Hydrolases / Q000378:metabolism; D015230:Prostaglandin D2; D011457:Prostaglandins D / Q000378:metabolism; D012220:Rhinitis / Q000628:therapy*; D012221:Rhinitis, Allergic, Perennial / Q000628:therapy*; D012882:Skin Tests; D013256:Steroids / Q000627:therapeutic use; D013566:Sympathomimetics / Q000494:pharmacology; D013997:Time Factors
D006634:Histamine H1 Antagonists; D011457:Prostaglandins D; D013256:Steroids; D013566:Sympathomimetics; D003907:Dexamethasone; D010447:Peptide Hydrolases; C023073:tosylarginine methyl ester hydrolase; D004205:Cromolyn Sodium; D015230:Prostaglandin D2